HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ku 0063794

an mTOR inhibitor; structure in first source
Also Known As:
Ku -0063794; Ku 63794; Ku-0063794; Ku-63794; Ku0063794; Ku63794; Benzenemethanol, 5-(2-((2R,6S)-2,6-dimethyl-4-morpholinyl)-4-(4-morpholinyl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxy-
Networked: 18 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Kim, Ok-Hee: 3 articles (01/2022 - 07/2018)
2. Kim, Say-June: 3 articles (01/2022 - 07/2018)
3. Hong, Ha Eun: 2 articles (01/2022 - 03/2021)
4. Kim, Kee-Hwan: 2 articles (03/2021 - 07/2018)
5. Weiss, William A: 2 articles (01/2020 - 01/2012)
6. Chen, Cong: 1 article (01/2022)
7. Jeon, Ye-Won: 1 article (01/2022)
8. Kim, Cho Hee: 1 article (01/2022)
9. Li, Sheng: 1 article (01/2022)
10. Li, Yumin: 1 article (01/2022)

Related Diseases

1. Breast Neoplasms (Breast Cancer)
2. Neoplasms (Cancer)
3. Hepatocellular Carcinoma (Hepatoma)
4. Glioblastoma (Glioblastoma Multiforme)
5. Hypoxia (Hypoxemia)

Related Drugs and Biologics

1. Docetaxel (Taxotere)
2. Mechanistic Target of Rapamycin Complex 1
3. Mechanistic Target of Rapamycin Complex 2
4. Sirolimus (Rapamycin)
5. Phosphotransferases (Kinase)
6. MTOR Inhibitors
7. Everolimus
8. PP242
9. PI103
10. temsirolimus